$LGND Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in LIGAND PHARMACEUTICALS INC.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in LIGAND PHARMACEUTICALS INC. Get notifications about new insider transactions in LIGAND PHARMACEUTICALS INC for free.

Page: < prev 1 2 3 4 5 6 ... 15 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Feb 18 2020	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	EVP,Finance & Strat ...	Option Exercise	A	95.68	30,750	2,942,160	30,750
Feb 18 2020	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	EVP,Finance & Strat ...	Grant	A	0.00	6,848	0	26,864	20 K to 26.9 K (+34.21 %)
Dec 26 2019	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	EVP,Finance & Strat ...	Payment of Exercise	F	105.87	979	103,647	20,016	21 K to 20 K (-4.66 %)
Dec 26 2019	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	EVP,Finance & Strat ...	Grant	A	0.00	2,305	0	20,995	18.7 K to 21 K (+12.33 %)
Dec 26 2019	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	EVP,Finance & Strat ...	Payment of Exercise	F	105.87	1,135	120,162	18,690	19.8 K to 18.7 K (-5.73 %)
Dec 26 2019	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	EVP,Finance & Strat ...	Grant	A	0.00	2,674	0	19,825	17.2 K to 19.8 K (+15.59 %)
Dec 26 2019	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Payment of Exercise	F	105.87	546	57,805	49,069	49.6 K to 49.1 K (-1.10 %)
Dec 26 2019	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Grant	A	0.00	1,335	0	49,615	48.3 K to 49.6 K (+2.77 %)
Dec 26 2019	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Payment of Exercise	F	105.87	585	61,934	48,280	48.9 K to 48.3 K (-1.20 %)
Dec 26 2019	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Grant	A	0.00	1,693	0	48,865	47.2 K to 48.9 K (+3.59 %)
Dec 26 2019	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Payment of Exercise	F	105.87	1,444	152,876	148,337	149.8 K to 148.3 K (-0.96 %)
Dec 26 2019	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Grant	A	0.00	2,913	0	149,781	146.9 K to 149.8 K (+1.98 %)
Dec 26 2019	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Payment of Exercise	F	105.87	2,210	233,973	146,868	149.1 K to 146.9 K (-1.48 %)
Dec 26 2019	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Grant	A	0.00	4,458	0	149,078	144.6 K to 149.1 K (+3.08 %)
Dec 26 2019	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Payment of Exercise	F	105.87	2,948	312,105	153,614	156.6 K to 153.6 K (-1.88 %)
Dec 26 2019	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Grant	A	0.00	5,946	0	156,562	150.6 K to 156.6 K (+3.95 %)
Dec 26 2019	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Payment of Exercise	F	105.87	3,801	402,412	150,616	154.4 K to 150.6 K (-2.46 %)
Dec 26 2019	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Grant	A	0.00	7,668	0	154,417	146.7 K to 154.4 K (+5.23 %)
Nov 13 2019	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Option Exercise	M	21.92	1,001	21,942	68,827
Nov 13 2019	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Buy	M	21.92	1,001	21,942	144,620	143.6 K to 144.6 K (+0.70 %)
Oct 16 2019	LGND	LIGAND PHARMACEUTI ...	Boyce Sarah	Director	Option Exercise	A	107.81	5,283	569,560	5,283
Oct 16 2019	LGND	LIGAND PHARMACEUTI ...	Boyce Sarah	Director	Grant	A	0.00	1,431	0	1,431	0 to 1.4 K
Sep 05 2019	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Option Exercise	M	21.92	1,005	22,030	69,828
Sep 05 2019	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Buy	M	21.92	1,005	22,030	143,619	142.6 K to 143.6 K (+0.70 %)
Sep 04 2019	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Buy	P	87.01	750	65,258	67,203	66.5 K to 67.2 K (+1.13 %)
Sep 03 2019	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	EVP,Finance & Strat ...	Buy	P	86.18	500	43,091	17,151	16.7 K to 17.2 K (+3.00 %)
Aug 13 2019	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Option Exercise	M	21.92	1,163	25,493	70,833
Aug 13 2019	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Buy	M	21.92	1,163	25,493	142,614	141.5 K to 142.6 K (+0.82 %)
Aug 06 2019	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Buy	P	90.01	746	67,146	66,453	65.7 K to 66.5 K (+1.14 %)
Aug 06 2019	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Option Exercise	M	85.79	424	36,375	4,153
Aug 06 2019	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Option Exercise	M	56.26	669	37,638	1,948
Aug 06 2019	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Buy	M	85.79	424	36,375	47,172	46.7 K to 47.2 K (+0.91 %)
Aug 06 2019	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Buy	M	56.26	669	37,638	46,748	46.1 K to 46.7 K (+1.45 %)
Aug 05 2019	LGND	LIGAND PHARMACEUTI ...	Davis Todd C	Director	Buy	P	93.59	1,000	93,594	49,474	48.5 K to 49.5 K (+2.06 %)
Aug 05 2019	LGND	LIGAND PHARMACEUTI ...	LAMATTINA JOHN L	Director	Option Exercise	M	32.30	2,500	80,750	4,835
Aug 05 2019	LGND	LIGAND PHARMACEUTI ...	LAMATTINA JOHN L	Director	Payment of Exercise	F	95.58	847	80,958	23,937	24.8 K to 23.9 K (-3.42 %)
Aug 05 2019	LGND	LIGAND PHARMACEUTI ...	LAMATTINA JOHN L	Director	Buy	M	32.30	2,500	80,750	24,784	22.3 K to 24.8 K (+11.22 %)
Aug 05 2019	LGND	LIGAND PHARMACEUTI ...	Patel Sunil	Director	Buy	P	95.98	1,000	95,980	26,359	25.4 K to 26.4 K (+3.94 %)
Aug 01 2019	LGND	LIGAND PHARMACEUTI ...	Sabba Stephen L	Director	Sell	S	94.45	4,091	386,395	23,600	27.7 K to 23.6 K (-14.77 %)
Jul 31 2019	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Buy	P	95.45	1,850	176,583	146,749	144.9 K to 146.7 K (+1.28 %)
Jul 31 2019	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Buy	P	93.00	754	70,122	65,707	65 K to 65.7 K (+1.16 %)
Jul 31 2019	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Buy	P	100.22	3,000	300,663	64,953	62 K to 65 K (+4.84 %)
Jul 31 2019	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Buy	P	106.01	250	26,503	61,953	61.7 K to 62 K (+0.41 %)
Jul 02 2019	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Buy	J	97.03	182	17,659	46,079	45.9 K to 46.1 K (+0.40 %)
Jul 02 2019	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	EVP,Finance & Strat ...	Buy	J	97.03	182	17,659	16,651	16.5 K to 16.7 K (+1.11 %)
Jun 12 2019	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Buy	P	107.01	250	26,753	61,703	61.5 K to 61.7 K (+0.41 %)
Jun 12 2019	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Option Exercise	M	21.92	1,004	22,008	71,996
Jun 12 2019	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Buy	M	21.92	1,004	22,008	141,451	140.4 K to 141.5 K (+0.71 %)
Jun 10 2019	LGND	LIGAND PHARMACEUTI ...	Sabba Stephen L	Director	Option Exercise	A	113.59	4,071	462,425	4,071
Jun 10 2019	LGND	LIGAND PHARMACEUTI ...	Sabba Stephen L	Director	Grant	A	0.00	835	0	27,691	26.9 K to 27.7 K (+3.11 %)
Jun 07 2019	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Option Exercise	A	113.59	4,071	462,425	4,071
Jun 07 2019	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Grant	A	0.00	835	0	61,453	60.6 K to 61.5 K (+1.38 %)
Jun 07 2019	LGND	LIGAND PHARMACEUTI ...	Davis Todd C	Director	Option Exercise	A	113.59	4,071	462,425	4,071
Jun 07 2019	LGND	LIGAND PHARMACEUTI ...	Davis Todd C	Director	Grant	A	0.00	835	0	48,474	47.6 K to 48.5 K (+1.75 %)
Jun 07 2019	LGND	LIGAND PHARMACEUTI ...	Gray Nancy Ryan	Director	Option Exercise	A	113.59	4,071	462,425	4,071
Jun 07 2019	LGND	LIGAND PHARMACEUTI ...	Gray Nancy Ryan	Director	Grant	A	0.00	835	0	2,241	1.4 K to 2.2 K (+59.39 %)
Jun 07 2019	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Option Exercise	A	113.59	4,071	462,425	4,071
Jun 07 2019	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Grant	A	0.00	835	0	26,377	25.5 K to 26.4 K (+3.27 %)
Jun 07 2019	LGND	LIGAND PHARMACEUTI ...	LAMATTINA JOHN L	Director	Option Exercise	A	113.59	4,071	462,425	4,071
Jun 07 2019	LGND	LIGAND PHARMACEUTI ...	LAMATTINA JOHN L	Director	Grant	A	0.00	835	0	22,284	21.4 K to 22.3 K (+3.89 %)
Jun 07 2019	LGND	LIGAND PHARMACEUTI ...	Patel Sunil	Director	Option Exercise	A	113.59	4,071	462,425	4,071
Jun 07 2019	LGND	LIGAND PHARMACEUTI ...	Patel Sunil	Director	Grant	A	0.00	835	0	25,359	24.5 K to 25.4 K (+3.40 %)
May 31 2019	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Buy	P	108.51	500	54,255	60,618	60.1 K to 60.6 K (+0.83 %)
May 31 2019	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Buy	P	110.01	250	27,503	60,118	59.9 K to 60.1 K (+0.42 %)
May 31 2019	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Buy	P	111.01	250	27,753	59,868	59.6 K to 59.9 K (+0.42 %)
May 31 2019	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Buy	P	108.20	1,000	108,202	144,899	143.9 K to 144.9 K (+0.69 %)
May 31 2019	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Buy	P	108.20	1,000	108,202	144,899	143.9 K to 144.9 K (+0.69 %)
May 22 2019	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Buy	P	112.01	250	28,003	59,618	59.4 K to 59.6 K (+0.42 %)
May 16 2019	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Buy	P	112.51	250	28,128	59,368	59.1 K to 59.4 K (+0.42 %)
May 14 2019	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Buy	P	113.50	2,500	283,750	143,899	141.4 K to 143.9 K (+1.77 %)
May 14 2019	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Option Exercise	M	17.88	2,500	44,700	0
May 14 2019	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Sell	S	112.92	2,500	282,300	25,542	28 K to 25.5 K (-8.92 %)
May 14 2019	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Buy	M	17.88	2,500	44,700	28,042	25.5 K to 28 K (+9.79 %)
Mar 15 2019	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Option Exercise	M	9.97	14,894	148,493	15,001
Mar 15 2019	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Buy	M	9.97	14,894	148,493	140,447	125.6 K to 140.4 K (+11.86 %)
Mar 15 2019	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Buy	P	112.51	202	22,727	51,594	51.4 K to 51.6 K (+0.39 %)
Mar 15 2019	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Buy	P	114.29	2,500	285,725	141,399	138.9 K to 141.4 K (+1.80 %)
Feb 13 2019	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	EVP,Finance & Strat ...	Option Exercise	A	117.97	29,298	3,456,285	29,298
Feb 13 2019	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	EVP,Finance & Strat ...	Grant	A	0.00	6,404	0	16,469	10.1 K to 16.5 K (+63.63 %)
Feb 13 2019	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Option Exercise	A	117.97	34,181	4,032,333	34,181
Feb 13 2019	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Grant	A	0.00	7,472	0	125,553	118.1 K to 125.6 K (+6.33 %)
Jan 25 2019	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Grant	A	0.00	1,412	0	42,695	41.3 K to 42.7 K (+3.42 %)
Jan 25 2019	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Grant	A	0.00	1,370	0	41,283	39.9 K to 41.3 K (+3.43 %)
Jan 25 2019	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Payment of Exercise	F	111.78	1,284	143,526	118,081	119.4 K to 118.1 K (-1.08 %)
Jan 25 2019	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Grant	A	0.00	3,715	0	119,365	115.7 K to 119.4 K (+3.21 %)
Jan 25 2019	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Payment of Exercise	F	111.78	1,284	143,526	115,650	116.9 K to 115.7 K (-1.10 %)
Jan 25 2019	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Grant	A	0.00	3,547	0	116,934	113.4 K to 116.9 K (+3.13 %)
Jan 25 2019	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Payment of Exercise	F	111.78	3,168	354,119	126,090	129.3 K to 126.1 K (-2.45 %)
Jan 25 2019	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Grant	A	0.00	6,390	0	129,258	122.9 K to 129.3 K (+5.20 %)
Jan 25 2019	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Payment of Exercise	F	111.78	3,597	402,073	122,868	126.5 K to 122.9 K (-2.84 %)
Jan 25 2019	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Grant	A	0.00	7,256	0	126,465	119.2 K to 126.5 K (+6.09 %)
Jan 25 2019	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	EVP,Finance & Strat ...	Payment of Exercise	F	111.78	612	68,409	10,065	10.7 K to 10.1 K (-5.73 %)
Jan 25 2019	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	EVP,Finance & Strat ...	Grant	A	0.00	2,230	0	10,677	8.4 K to 10.7 K (+26.40 %)
Jan 25 2019	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	EVP,Finance & Strat ...	Payment of Exercise	F	111.78	713	79,699	8,447	9.2 K to 8.4 K (-7.78 %)
Jan 25 2019	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	EVP,Finance & Strat ...	Grant	A	0.00	2,418	0	9,160	6.7 K to 9.2 K (+35.86 %)
Jan 14 2019	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Option Exercise	M	74.42	1,931	143,705	0
Jan 14 2019	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Option Exercise	M	56.26	675	37,976	2,617
Jan 14 2019	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Option Exercise	M	21.92	244	5,348	0
Jan 14 2019	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Buy	M	56.26	675	37,976	39,913	39.2 K to 39.9 K (+1.72 %)
Jan 14 2019	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Buy	M	74.42	1,931	143,705	39,238	37.3 K to 39.2 K (+5.18 %)
Jan 14 2019	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Buy	M	21.92	244	5,348	37,307	37.1 K to 37.3 K (+0.66 %)
Jan 14 2019	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Option Exercise	M	16.14	4,000	64,560	0
Jan 14 2019	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Option Exercise	M	16.14	29,790	480,811	0
Jan 14 2019	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Buy	M	16.14	29,790	480,811	119,209	89.4 K to 119.2 K (+33.32 %)
Jan 14 2019	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Buy	M	16.14	4,000	64,560	89,419	85.4 K to 89.4 K (+4.68 %)
Dec 17 2018	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Option Exercise	M	21.92	3,400	74,528	244
Dec 17 2018	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Option Exercise	M	21.92	3,400	74,528	244
Dec 17 2018	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Buy	M	21.92	3,400	74,528	37,063	33.7 K to 37.1 K (+10.10 %)
Dec 17 2018	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Buy	M	21.92	3,400	74,528	37,063	33.7 K to 37.1 K (+10.10 %)
Dec 12 2018	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Option Exercise	M	9.97	7,999	79,750	29,895
Dec 12 2018	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Buy	M	9.97	7,999	79,750	113,387	105.4 K to 113.4 K (+7.59 %)
Oct 25 2018	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Option Exercise	M	14.47	2,688	38,895	0
Oct 25 2018	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Option Exercise	M	21.92	1,212	26,567	3,644
Oct 25 2018	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Buy	M	21.92	1,212	26,567	33,663	32.5 K to 33.7 K (+3.73 %)
Oct 25 2018	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Buy	M	14.47	2,688	38,895	32,451	29.8 K to 32.5 K (+9.03 %)
Oct 15 2018	LGND	LIGAND PHARMACEUTI ...	Davis Todd C	Director	Option Exercise	M	119.30	2,329	277,850	0
Oct 15 2018	LGND	LIGAND PHARMACEUTI ...	Davis Todd C	Director	Option Exercise	M	89.75	2,754	247,172	0
Oct 15 2018	LGND	LIGAND PHARMACEUTI ...	Davis Todd C	Director	Buy	M	119.30	2,329	277,850	47,639	45.3 K to 47.6 K (+5.14 %)
Oct 15 2018	LGND	LIGAND PHARMACEUTI ...	Davis Todd C	Director	Buy	M	89.75	2,754	247,172	45,310	42.6 K to 45.3 K (+6.47 %)
Oct 12 2018	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Option Exercise	M	14.47	2,000	28,940	2,688
Oct 12 2018	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Buy	M	14.47	2,000	28,940	29,763	27.8 K to 29.8 K (+7.20 %)
Oct 09 2018	LGND	LIGAND PHARMACEUTI ...	Davis Todd C	Director	Sell	S	253.99	2,500	634,978	42,556	45.1 K to 42.6 K (-5.55 %)
Oct 02 2018	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Sell	S	275.04	2,500	687,610	26,142	28.6 K to 26.1 K (-8.73 %)
Oct 02 2018	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Option Exercise	M	14.47	12,000	173,640	21,675
Oct 02 2018	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Option Exercise	M	9.97	2,088	20,817	37,894
Oct 02 2018	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Sell	S	273.88	12,000	3,286,560	105,388	117.4 K to 105.4 K (-10.22 %)
Oct 02 2018	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Buy	M	14.47	12,000	173,640	117,388	105.4 K to 117.4 K (+11.39 %)
Oct 02 2018	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Buy	M	9.97	2,088	20,817	105,388	103.3 K to 105.4 K (+2.02 %)
Sep 27 2018	LGND	LIGAND PHARMACEUTI ...	LIGAND PHARMACEUTICALS INC	10% Owner	Option Exercise	J	0.00	1,916,509	0	0
Sep 27 2018	LGND	LIGAND PHARMACEUTI ...	LIGAND PHARMACEUTICALS INC	10% Owner	Option Exercise	J	0.00	38,630	0	1,916,509
Sep 27 2018	LGND	LIGAND PHARMACEUTI ...	LIGAND PHARMACEUTICALS INC	10% Owner	Sell	S	19.15	262,881	5,034,250	6,038,083	6.3 M to 6 M (-4.17 %)
Sep 18 2018	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Option Exercise	M	100.38	2,813	282,369	6,830
Sep 18 2018	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Sell	S	250.69	2,813	705,181	27,763	30.6 K to 27.8 K (-9.20 %)
Sep 18 2018	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Buy	M	100.38	2,813	282,369	30,576	27.8 K to 30.6 K (+10.13 %)
Sep 06 2018	LGND	LIGAND PHARMACEUTI ...	Sabba Stephen L	Director	Option Exercise	M	17.88	2,500	44,700	0
Sep 06 2018	LGND	LIGAND PHARMACEUTI ...	Sabba Stephen L	Director	Option Exercise	M	8.58	2,500	21,450	0
Sep 06 2018	LGND	LIGAND PHARMACEUTI ...	Sabba Stephen L	Director	Sell	S	255.05	5,000	1,275,250	26,856	31.9 K to 26.9 K (-15.70 %)
Sep 06 2018	LGND	LIGAND PHARMACEUTI ...	Sabba Stephen L	Director	Buy	M	17.88	2,500	44,700	31,856	29.4 K to 31.9 K (+8.52 %)
Sep 06 2018	LGND	LIGAND PHARMACEUTI ...	Sabba Stephen L	Director	Buy	M	8.58	2,500	21,450	29,356	26.9 K to 29.4 K (+9.31 %)
Sep 05 2018	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Option Exercise	M	14.47	12,000	173,640	33,675
Sep 05 2018	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Option Exercise	M	9.97	1,044	10,409	39,982
Sep 05 2018	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Sell	S	255.01	12,000	3,060,082	103,300	115.3 K to 103.3 K (-10.41 %)
Sep 05 2018	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Buy	M	14.47	12,000	173,640	115,300	103.3 K to 115.3 K (+11.62 %)
Sep 05 2018	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Buy	M	9.97	1,044	10,409	103,300	102.3 K to 103.3 K (+1.02 %)
Sep 05 2018	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Option Exercise	M	21.92	469	10,280	0
Sep 05 2018	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Option Exercise	M	85.79	5,886	504,960	4,577
Sep 05 2018	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Option Exercise	M	74.42	5,985	445,404	1,931
Sep 05 2018	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Option Exercise	M	56.26	7,077	398,152	3,292
Sep 05 2018	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Sell	S	254.99	19,417	4,951,065	27,763	47.2 K to 27.8 K (-41.16 %)
Sep 05 2018	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Buy	M	85.79	5,886	504,960	47,180	41.3 K to 47.2 K (+14.25 %)

Page: < prev 1 2 3 4 5 6 ... 15 next >